Characterizing the pocketome of Mycobacterium tuberculosis and rationalization of polypharmacological target selection.

Mapping the small molecule binding pocket space in Mtb: Characterization of the MtbPocketome

Following files contain the information on the tripartite network constructure between protein-ligand associations obtained from kegg, chemical similarity associations obtained between KEGG ligands and PDB ligands, and finally protein-ligand association obtained for chemically similar ligands in PDB through PocketMatch.

Binding site space of Mtb proteome is much higher than the sequence or the fold space

Following files contains the supporting information on binding site space and the sequence-structure-pocket relationship.

Identifying polypharmacological target sets from Mtb binding site similarity network

All the supporting files for obtaining the polypharmacological sets from sequence,structure and pocket similarity is given in these files.

Comparison of Mtbpocketome with known drug-binding sites

These files contain the information on drug associations obtained through comparison of drug binding sites obtained from drugbank.

Clues for drug-repurposing

These files contain the supporting information on the associations obtained between high-confidence targets from targetTB and approved drugs through binding site comparison using PocketMatch algorithm.
  • Protein_drug_association.tsv - This csv file contains the information on drug association for protein pockets within Mtb.
  • Drug-target_graph.cys - This file is the cytoscape session of drug-target network in this study. Please follow this link: http://wiki.cytoscape.org/GettingStarted for downloading Cytoscape and opening the session file.
  • Targets_description.xlsx - This microsoft excel file contains the information of targets present in the network, prioritized according to their clustering-coefficient in the network.
  • Drug_repurposing.xlsx - This microsoft excel file contains the information of drugs that could have potential of repurposing for antimycobacterial activity, prioritized according to clustering coefficient in drug-target network.